Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms

Background Patients with advanced lung neuroendocrine neoplasms (NENs) have few treatment options. Capecitabine and temozolomide have recently showed significant activity in patients with pancreatic neuroendocrine tumors (NETs), but data in lung NETs are limited. Methods We retrospectively reviewed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2020-01, Vol.25 (1), p.e48-e52
Hauptverfasser:	Al‐Toubah, Taymeyah, Morse, Brian, Strosberg, Jonathan
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Atypical carcinoid Bronchial Capecitabine Capecitabine - pharmacology Capecitabine - therapeutic use Endocrinology Female Humans Lung Male Middle Aged Neuroendocrine neoplasm Neuroendocrine tumor Neuroendocrine Tumors - drug therapy Neuroendocrine Tumors - pathology Retrospective Studies Temozolomide Temozolomide - pharmacology Temozolomide - therapeutic use Treatment Outcome Typical carcinoid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!